- Home
- MOLN vs MED Comparison
MOLN vs MED Comparison
Compare MOLN & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- MED
- Stock Information
- Founded
- MOLN 2004
- MED 1980
- Country
- MOLN Switzerland
- MED United States
- Employees
- MOLN N/A
- MED N/A
- Industry
- MOLN
- MED Packaged Foods
- Sector
- MOLN
- MED Consumer Staples
- Exchange
- MOLN Nasdaq
- MED Nasdaq
- Market Cap
- MOLN 192.4M
- MED 187.3M
- IPO Year
- MOLN 2021
- MED N/A
- Fundamental
- Price
- MOLN $5.04
- MED $15.48
- Analyst Decision
- MOLN
- MED Hold
- Analyst Count
- MOLN 0
- MED 1
- Target Price
- MOLN N/A
- MED $17.00
- AVG Volume (30 Days)
- MOLN 5.7K
- MED 204.6K
- Earning Date
- MOLN 03-13-2025
- MED 02-18-2025
- Dividend Yield
- MOLN N/A
- MED N/A
- EPS Growth
- MOLN N/A
- MED N/A
- EPS
- MOLN N/A
- MED 0.67
- Revenue
- MOLN $7,105,397.00
- MED $674,475,000.00
- Revenue This Year
- MOLN N/A
- MED N/A
- Revenue Next Year
- MOLN $29.41
- MED N/A
- P/E Ratio
- MOLN N/A
- MED $23.25
- Revenue Growth
- MOLN N/A
- MED N/A
- 52 Week Low
- MOLN $3.32
- MED $14.88
- 52 Week High
- MOLN $12.70
- MED $56.52
- Technical
- Relative Strength Index (RSI)
- MOLN 41.97
- MED 36.38
- Support Level
- MOLN $5.22
- MED $15.67
- Resistance Level
- MOLN $5.35
- MED $16.30
- Average True Range (ATR)
- MOLN 0.12
- MED 0.55
- MACD
- MOLN -0.03
- MED 0.09
- Stochastic Oscillator
- MOLN 0.00
- MED 25.16
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About MED MEDIFAST INC
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.